Latest filings (excl ownership)
D/A
Indefinite amount in investment fund, sold $1.51 bn, 27 investors
29 Dec 23
D/A
Indefinite amount in investment fund, sold $1.51 bn, 27 investors
30 Dec 22
D/A
Indefinite amount in investment fund, sold $1.11B, 26 investors
4 Jan 22
D/A
Indefinite amount in investment fund, sold $675.08M, 24 investors
7 Jan 21
D/A
Indefinite amount in investment fund, sold $413.83M, 19 investors
10 Jan 20
D/A
Indefinite amount in investment fund, sold $224.03M, 18 investors
11 Jan 19
D/A
Indefinite amount in investment fund, sold $224.03M, 18 investors
8 Dec 17
D/A
Indefinite amount in investment fund, sold $212.03M, 17 investors
21 Sep 16
D/A
Indefinite amount in investment fund, sold $64.76M, 13 investors
12 Nov 14
D/A
Indefinite amount in investment fund, sold $41.66M, 14 investors
8 Nov 13
D/A
Indefinite amount in investment fund, sold $37.66M, 12 investors
8 Nov 12
D/A
Indefinite amount in investment fund, sold $36.16M, 12 investors
8 Nov 11
D
Indefinite amount in investment fund, sold $34.91M, 12 investors
21 Oct 10
D/A
Indefinite amount in investment fund, sold $29.16M, 12 investors
15 Oct 09
SC TO-T/A
Third party tender offer statement (amended)
27 Mar 09
DFAN14A
Additional proxy materials by non-management
23 Mar 09
DFAN14A
Additional proxy materials by non-management
20 Mar 09
SC TO-T/A
Third party tender offer statement (amended)
20 Mar 09
DFAN14A
Additional proxy materials by non-management
13 Mar 09
DFAN14A
Additional proxy materials by non-management
13 Mar 09
DFAN14A
Additional proxy materials by non-management
12 Mar 09
DEFC14A
Proxy in contested solicitation
10 Mar 09
DFAN14A
Additional proxy materials by non-management
10 Mar 09
SC TO-T/A
Third party tender offer statement (amended)
9 Mar 09
CORRESP
Correspondence with SEC
5 Mar 09
SC TO-T/A
Third party tender offer statement (amended)
23 Feb 09
DFAN14A
Additional proxy materials by non-management
10 Feb 09
DFAN14A
Additional proxy materials by non-management
6 Feb 09
SC TO-T/A
Third party tender offer statement (amended)
6 Feb 09
PRRN14A
Revised preliminary proxy statement filed by non-management
5 Feb 09
PRRN14A
Revised preliminary proxy statement filed by non-management
29 Jan 09
CORRESP
Correspondence with SEC
20 Jan 09
DFAN14A
Additional proxy materials by non-management
15 Jan 09
SC TO-C
Information about tender offer
15 Jan 09
PREC14A
Preliminary proxy with contested solicitation
13 Jan 09
DFAN14A
Additional proxy materials by non-management
9 Jan 09
REGDEX
Notice of sale of securities
2 Oct 08
REGDEX
Notice of sale of securities
13 Feb 03
Latest ownership filings
SC 13D/A
MoonLake Immunotherapeutics
5 Mar 24
SC 13G/A
enGene Holdings Inc.
22 Feb 24
SC 13G/A
Aclaris Therapeutics, Inc.
14 Feb 24
SC 13G/A
AILERON THERAPEUTICS INC
14 Feb 24
SC 13G/A
Annexon, Inc.
14 Feb 24
SC 13G/A
Aravive, Inc.
14 Feb 24
SC 13G/A
ASLAN Pharmaceuticals Ltd
14 Feb 24
SC 13G/A
BIONOMICS LIMITED/FI
14 Feb 24
SC 13G/A
Cidara Therapeutics, Inc.
14 Feb 24
SC 13G/A
Cullinan Oncology, Inc.
14 Feb 24
SC 13G/A
Centessa Pharmaceuticals plc
14 Feb 24
SC 13G/A
Crinetics Pharmaceuticals, Inc.
14 Feb 24
SC 13G/A
CytomX Therapeutics, Inc.
14 Feb 24
SC 13G/A
DELCATH SYSTEMS, INC.
14 Feb 24
SC 13G/A
Eledon Pharmaceuticals, Inc.
14 Feb 24
SC 13G/A
Elevation Oncology, Inc.
14 Feb 24
SC 13G/A
89bio, Inc.
14 Feb 24
SC 13G/A
4D Molecular Therapeutics, Inc.
14 Feb 24
SC 13G/A
GH Research PLC
14 Feb 24
SC 13G/A
Galmed Pharmaceuticals Ltd.
14 Feb 24
SC 13G/A
IDEAYA Biosciences, Inc.
14 Feb 24
SC 13G/A
Ikena Oncology, Inc.
14 Feb 24
SC 13G/A
iTeos Therapeutics, Inc.
14 Feb 24
SC 13G/A
Janux Therapeutics, Inc.
14 Feb 24
SC 13G/A
Jasper Therapeutics, Inc.
14 Feb 24
SC 13G/A
Kura Oncology, Inc.
14 Feb 24
SC 13G/A
LEXICON PHARMACEUTICALS, INC.
14 Feb 24
SC 13G/A
Merus N.V.
14 Feb 24
SC 13G/A
Molecular Templates, Inc.
14 Feb 24
SC 13G/A
Protagonist Therapeutics, Inc
14 Feb 24
SC 13G/A
Pyxis Oncology, Inc.
14 Feb 24
SC 13G/A
Revolution Medicines, Inc.
14 Feb 24
SC 13G/A
Tyra Biosciences, Inc.
14 Feb 24
SC 13G/A
Viridian Therapeutics, Inc.\DE
14 Feb 24
SC 13G/A
Verastem, Inc.
14 Feb 24
4
MARK N LAMPERT
29 Jan 24
SC 13D/A
Rain Oncology Inc.
29 Jan 24
SC 13G/A
GLYCOMIMETICS INC
29 Jan 24
3
MARK N LAMPERT
26 Jan 24
SC 13G/A
Allakos Inc.
18 Jan 24